| Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability S Srivastava, JG Pasipanodya, C Meek, R Leff, T Gumbo The Journal of infectious diseases 204 (12), 1951-1959, 2011 | 333 | 2011 |
| Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs T Gumbo, CSW Siyambalapitiyage Dona, C Meek, R Leff Antimicrobial agents and chemotherapy 53 (8), 3197-3204, 2009 | 211 | 2009 |
| The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance AM Schmalstieg, S Srivastava, S Belkaya, D Deshpande, C Meek, R Leff, ... Antimicrobial agents and chemotherapy 56 (9), 4806-4815, 2012 | 199 | 2012 |
| Caffeine citrate for the treatment of apnea of prematurity: a double‐blind, placebo‐controlled study A Erenberg, RD Leff, DG Haack, KW Mosdell, GM Hicks, BA Wynne, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (6 …, 2000 | 166 | 2000 |
| Efflux-Pump—Derived Multiple Drug Resistance to Ethambutol Monotherapy in Mycobacterium tuberculosis and the Pharmacokinetics and Pharmacodynamics of … S Srivastava, S Musuka, C Sherman, C Meek, R Leff, T Gumbo The Journal of infectious diseases 201 (8), 1225-1231, 2010 | 153 | 2010 |
| Ribavirin improves early responses to peginterferon through improved interferon signaling JJ Feld, GA Lutchman, T Heller, K Hara, JK Pfeiffer, RD Leff, C Meek, ... Gastroenterology 139 (1), 154-162. e4, 2010 | 143 | 2010 |
| Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin AJ Busti, AM Bain, RG Hall, RG Bedimo, RD Leff, C Meek, R Mehvar Journal of cardiovascular pharmacology 51 (6), 605-610, 2008 | 130 | 2008 |
| Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations JS Gewandter, RH Dworkin, DC Turk, MP McDermott, R Baron, ... PAIN® 155 (9), 1683-1695, 2014 | 115 | 2014 |
| Treatment of active pulmonary tuberculosis in adults: current standards and recent advances: insights from the Society of Infectious Diseases Pharmacists RG Hall, RD Leff, T Gumbo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (12 …, 2009 | 101 | 2009 |
| Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis DE Gerber, MS Beg, F Fattah, AE Frankel, O Fatunde, Y Arriaga, ... British journal of cancer 119 (8), 928-936, 2018 | 74 | 2018 |
| Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular … D Deshpande, S Srivastava, C Meek, R Leff, T Gumbo Antimicrobial agents and chemotherapy 54 (5), 1728-1733, 2010 | 68 | 2010 |
| Safety and efficacy of a topical anesthetic for neonatal circumcision KB Weatherstone, LB Rasmussen, A Erenberg, EM Jackson, KS Claflin, ... Pediatrics 92 (5), 710-714, 1993 | 66 | 1993 |
| Influence of infusion pump operation and flow rate on hemodynamic stability during epinephrine infusion SA Klem, JM Farrington, RD Leff Critical care medicine 21 (8), 1213-1217, 1993 | 64 | 1993 |
| Continuous intravenous morphine infusion in postoperative newborn infants EA Farrington, GA McGuinness, GF Johnson, A Erenberg, RD Leff American journal of perinatology 10 (01), 84-87, 1993 | 62 | 1993 |
| Pharmacokinetics of oseltamivir according to trimester of pregnancy LG Greer, RD Leff, VL Rogers, SW Roberts, GH McCracken Jr, ... American journal of obstetrics and gynecology 204 (6), S89-S93, 2011 | 58 | 2011 |
| Effects of intravenous delivery systems on infused red blood cells JS Gibson, RD Leff, RJ Roberts American journal of hospital pharmacy 41 (3), 468-472, 1984 | 58 | 1984 |
| Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection D Deshpande, S Srivastava, C Meek, R Leff, GS Hall, T Gumbo Antimicrobial agents and chemotherapy 54 (6), 2534-2539, 2010 | 55 | 2010 |
| Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths RG Hall, MA Swancutt, C Meek, R Leff, T Gumbo Antimicrobial agents and chemotherapy 57 (5), 2259-2264, 2013 | 53 | 2013 |
| Forced expiratory volume in 1 second variability helps identify patients with cystic fibrosis at risk of greater loss of lung function WJ Morgan, DR Vandevanter, DJ Pasta, AJ Foreman, JS Wagener, ... The Journal of pediatrics 169, 116-121. e2, 2016 | 51 | 2016 |
| Thioridazine pharmacokinetic-pharmacodynamic parameters “wobble” during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners S Musuka, S Srivastava, CW Siyambalapitiyage Dona, C Meek, R Leff, ... Antimicrobial agents and chemotherapy 57 (12), 5870-5877, 2013 | 51 | 2013 |
